8-K/A
Current Report
Alaunos Therapeutics, Inc. Filed Acc 0001193125-16-640603
Material agreement · Bylaws or fiscal year change
- Item 1.01 Entry into a material definitive agreement
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
From the SEC's structured data for this filing
Loading d220092d8ka.htm…